Neera Dahl, MD, PhD
DownloadHi-Res Photo
Cards
Appointments
Nephrology
Primary
Titles
Medical Director, Outpatient Dialysis, Nephrology; Director, Nephrology Clinical Trials Program, Nephrology
Contact Info
Appointments
Nephrology
Primary
Titles
Medical Director, Outpatient Dialysis, Nephrology; Director, Nephrology Clinical Trials Program, Nephrology
Contact Info
Appointments
Nephrology
Primary
Titles
Medical Director, Outpatient Dialysis, Nephrology; Director, Nephrology Clinical Trials Program, Nephrology
Contact Info
About
Titles
Professor Adjunct
Medical Director, Outpatient Dialysis, Nephrology; Director, Nephrology Clinical Trials Program, NephrologyBiography
Dr. Dahl has expertise in diagnosis and management of inherited (or genetically based) kidney disease. Her main focus has been ADPKD and other cystic kidney diseases which mimic ADPKD. She is the medical director of the New Haven DaVita unit providing in center hemodialysis, home hemodialysis and peritoneal dialysis. She is the Director of the Nephrology Clinical Trials program overseeing studies in ADPKD, diabetes and hypertension. In collaboration with Dr. Dinesh Singh she runs the Yale Kidney Stone Clinic.
Appointments
Nephrology
Professor AdjunctPrimary
Other Departments & Organizations
- Chronic Kidney Disease Program
- Internal Medicine
- Nephrology
- Prostate & Urologic Cancers Program
- Yale Cancer Center
- Yale Ventures
Education & Training
- Fellow
- Beth Israel Deaconess Medical Center (2002)
- Resident
- Beth Israel Deaconess Medical Center (1999)
- Intern
- BIDMC, Harvard Medical School (1997)
- PhD
- Tufts University (1996)
- MD
- Tufts University School of Medicine (1996)
- BA
- Johns Hopkins University (1987)
- Postdoctoral, PhD
- Tufts University School of Medicine and Sackler School of Biomedical Science
Research
Overview
In collaboration with Dr. Tinika Montgomery (nephrology), Drs. Dinesh Singh, Piruz Motamedinia, and Tim Tran (urology) we have created a Kidney Stone Registry to track important aspects of kidney stone management.
In the inherited kidney disease space I am most interested in those aspects of clinical research which improve care for ADPKD patients.
Medical Subject Headings (MeSH)
Kidney Diseases; Nephrology
Research at a Glance
Yale Co-Authors
Frequent collaborators of Neera Dahl's published research.
Publications Timeline
A big-picture view of Neera Dahl's research output by year.
Research Interests
Research topics Neera Dahl is interested in exploring.
Cassius Iyad Ochoa Chaar, MD, MPH, MS, RPVI
Gilbert Moeckel, MD, PhD, FASN
Stefan Somlo, MD
Whitney Besse, MD
Abinet Aklilu, MD, MPH
Margaret Bia, MD
71Publications
950Citations
Kidney Diseases
Nephrology
Publications
2024
Kidney Stones Account for Increased Imaging Studies in Autosomal Dominant Polycystic Kidney Disease
Simmons K, Ullman L, Dahl N. Kidney Stones Account for Increased Imaging Studies in Autosomal Dominant Polycystic Kidney Disease. Kidney360 2024, 5: 707-714. PMID: 38526140, PMCID: PMC11146651, DOI: 10.34067/kid.0000000000000424.Peer-Reviewed Original ResearchAltmetricConceptsAbdominal imaging studiesChronic kidney diseaseADPKD patientsImaging studiesKidney stonesChronic kidney disease controlKidney diseaseChronic kidney disease groupIncreased incidence of kidney stonesChronic kidney disease populationChronic kidney disease stagePreserved renal functionRetrospectively reviewed patientsAutosomal dominant polycystic kidney diseaseIncidence of kidney stonesDominant polycystic kidney diseaseChi-square and t-testsCoronary artery diseasePolycystic kidney diseaseCompared to controlsCyst complicationsRenal functionChart reviewLower BMIManual chart reviewPain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry
Hoover E, Holliday V, Merullo N, Oberdhan D, Perrone R, Rusconi C, Park M, Phadnis M, Thewarapperuma N, Dahl N. Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry. Kidney Medicine 2024, 6: 100813. PMID: 38689835, PMCID: PMC11059322, DOI: 10.1016/j.xkme.2024.100813.Peer-Reviewed Original ResearchCitationsAltmetricConceptsHealth-related quality of lifeQuality of lifeHRQoL toolsOutcomes health-related quality of lifeDisease-specific assessment toolsHealth care accessCore outcome domainsDisease-specific patientHealth-related qualityBurden of painCross-sectional assessmentHRQoL modulePositive HRQoLPain interferenceCare accessHealthcare accessPatient experienceConsenting participantsCore questionnaireOutcome domainsImpact ScalePain severityEmotional distressHRQoLPatient reportsWhat is the Appropriate Dose of Tolvaptan in ADPKD?
Dahl N, Torres V. What is the Appropriate Dose of Tolvaptan in ADPKD? Kidney International Reports 2024, 9: 737-739. PMID: 38765581, PMCID: PMC11101796, DOI: 10.1016/j.ekir.2024.01.049.Peer-Reviewed Original ResearchCitationsAltmetric
2023
Beyond Loss of Kidney Function: Patient Care in Autosomal Dominant Polycystic Kidney Disease
Hogan M, Simmons K, Ullman L, Gondal M, Dahl N. Beyond Loss of Kidney Function: Patient Care in Autosomal Dominant Polycystic Kidney Disease. Kidney360 2023, 4: 1806-1815. PMID: 38010035, PMCID: PMC10758524, DOI: 10.34067/kid.0000000000000296.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAutosomal dominant polycystic kidney diseaseDominant polycystic kidney diseasePolycystic kidney diseaseKidney diseaseKidney Disease Improving Global Outcomes guidelinesGlobal Outcomes (KDIGO) guidelinesInitiation of RRTSuccessful kidney transplantEvidence-based guidelinesCurrent clinical practiceKidney stone managementMajor morbidityCardiac manifestationsKidney transplantOutcomes guidelinesKidney functionDepression screeningDisease benefitPancreatic cystsSpecialized careRoutine managementClinical practicePatient careStone managementDisease aspectsThe VUS Challenge in Cystic Kidney Disease: A Case-Based Review
Aklilu A, Gulati A, Kolber K, Yang H, Harris P, Dahl N. The VUS Challenge in Cystic Kidney Disease: A Case-Based Review. Kidney360 2023, 5: 152-159. PMID: 37962562, PMCID: PMC10833605, DOI: 10.34067/kid.0000000000000298.Peer-Reviewed Original ResearchCitationsAltmetricConceptsAutosomal dominant polycystic kidney diseaseKidney diseaseHigh pre-test probabilityGenetic testingCase-based reviewPre-test probabilityDominant polycystic kidney diseaseRoutine genetic testingPost-test genetic counselingCystic kidney diseasePolycystic kidney diseaseFurther family studiesNephrology clinicKidney failureClinical criteriaCystic disordersOrdering clinicianCommon causeAppropriate carePathogenic variantsACMG guidelinesClinical settingDiagnostic groupingsUncertain significanceGenetic reportsA Diagnosis of Depression/Anxiety Is Associated with More Rapid eGFR Decline in Autosomal Dominant Polycystic Kidney Disease
Simmons K, Ullman L, Dahl N. A Diagnosis of Depression/Anxiety Is Associated with More Rapid eGFR Decline in Autosomal Dominant Polycystic Kidney Disease. Journal Of The American Society Of Nephrology 2023, 34: 214-214. DOI: 10.1681/asn.20233411s1214a.Peer-Reviewed Original ResearchCitationsState of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies
Thompson W, Babayev S, McGowan M, Kattah A, Wick M, Bendel-Stenzel E, Chebib F, Harris P, Dahl N, Torres V, Hanna C. State of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies. Journal Of The American Society Of Nephrology 2023, 35: 235-248. PMID: 37882743, PMCID: PMC10843344, DOI: 10.1681/asn.0000000000000253.Peer-Reviewed Original ResearchCitationsAltmetricThe Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease
Dahl N, Bloom M, Chebib F, Clark D, Westemeyer M, Jandeska S, Zhang Z, Milo-Rasouly H, Kolupaeva V, Marasa M, Broumand V, Fatica R, Raj D, Demko Z, Marshall K, Punj S, Tabriziani H, Bhorade S, Gharavi A. The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease. Journal Of The American Society Of Nephrology 2023, 34: 2039-2050. PMID: 37794564, PMCID: PMC10703084, DOI: 10.1681/asn.0000000000000249.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPositive genetic findingsCKD diagnosisGenetic testingGenetic findingsClinical managementCLINICAL TRIAL REGISTRY NAMEUnderlying causeGene panelTRIAL REGISTRY NAMEChronic kidney diseaseManagement of adultsAppropriate treatment strategyClinical care paradigmsPatient's medical historyClinical applicationAcademic medical centerClinical disease categoriesAdult patientsREGISTRY NAMEPrior diagnosisKidney diseaseMulticenter studyMedical historyTreatment strategiesMedical CenterPolycystic Kidney Disease Diet
Chebib F, Nowak K, Chonchol M, Bing K, Ghanem A, Rahbari-Oskoui F, Dahl N, Mrug M. Polycystic Kidney Disease Diet. Clinical Journal Of The American Society Of Nephrology 2023, 19: 664-682. PMID: 37729939, PMCID: PMC11108253, DOI: 10.2215/cjn.0000000000000326.Peer-Reviewed Original ResearchCitationsAltmetricConceptsAutosomal dominant polycystic kidney diseaseDietary interventionCaloric restrictionIntermittent fastingMetabolic healthClinical trialsProgressive kidney function lossUncertain clinical benefitKidney function lossIdeal body weightExtensive clinical researchHigh fluid intakeLimited clinical evidenceDominant polycystic kidney diseasePolycystic kidney diseasePersonalized dietary guidelinesConcentrated sweetsAdverse eventsKetogenic dietClinical benefitClinical evidenceKidney diseaseADPKD progressionWeight managementFavorable outcomeHybrid Revision of Dysfunctional Aneurysmal Arteriovenous Fistulas
Kostiuk V, Chen J, Dahl N, Turner J, Chaar C. Hybrid Revision of Dysfunctional Aneurysmal Arteriovenous Fistulas. Vascular And Endovascular Surgery 2023, 57: 909-913. PMID: 37300698, DOI: 10.1177/15385744231183488.Peer-Reviewed Original Research
Clinical Trials
Current Trials
Genetic Determinants of Aneurysms in Autosomal Dominant Polycystic Kidney Disease
HIC ID2000029350RoleSub InvestigatorPrimary Completion Date12/31/2022Recruiting ParticipantsGenderBothAge18+ yearsScreening In Anticipation of Future Research
HIC ID2000021443RoleSub InvestigatorPrimary Completion Date12/31/2022Recruiting ParticipantsGenderBothAge2 years - 17 yearsGenetic Studies of Polycystic Livers
HIC ID0003010983RoleSub InvestigatorPrimary Completion Date04/01/2024Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements and Community Involvement
activity Advisor, Scientific Advisory Board
Advisory BoardsPKD FoundationDetails10/01/2018 - PresentDescriptioninvolved in grant review and patient outreach projects with the PKD Foundationactivity Board Member, Medical Review Board
Advisory BoardsESRD Network of New EnglandDetails10/01/2015 - PresentDescriptionHelped determine focus of the ESRD Network projectsactivity Board Member, National Kidney Foundation, CT Chapter
Advisory BoardsNational Kidney FoundationDetails10/01/2008 - Presentactivity Reviewer
Journal ServiceAmerican Journal of Kidney DiseaseDetails2007 - Presentactivity Reviewer
Journal ServiceClinical Journal of the American Society of NephrologyDetails2007 - Present
Links & Media
News
- February 15, 2024
Hybrid Approach to Arteriovenous Fistula Aneurysm Repair
- July 13, 2023
Support System, Consistency Important For Dialysis Patients During Pandemic (Discoveries & Impact July 2023)
- December 19, 2022
Yale Named Center of Excellence by Polycystic Kidney Disease (PKD) Foundation
- November 12, 2022Source: Web MD
Talking to Your Kids About ADPKD
Get In Touch
Contacts
Administrative Support